Investigated event: Influence on cell viability

Name Value
Compound LLL-12
Investigated event Influence on cell viability
Experiment type MTT
Concentration 2.50 µM
Cell line Hep3B
Organism Homo sapiens
Animal model
STAT protein
Other
Reference
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy. Oncotarget Mingxin Zuo, Chenglong Li, Jiayuh Lin, Milind Javle, 6, 13, 2015-05-10, None, 10.18632/oncotarget.3458 DOI: 10.18632/oncotarget.3458 PUBMED: 25883212 PMCID: PMC4484430